Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes

摘要

The present invention relates to physical crystal structures of a compound of the formula I:
wherein R 1 , R 2 , R 2a , R 3 and R 4 are as defined herein, especially
pharmaceutical compositions containing structures of compound I or II, processes for preparing same, intermediates used in preparing same, and methods of treating diseases such as diabetes using such structures.